scispace - formally typeset
S

Saeed Ghasemi

Researcher at University of Gilan

Publications -  25
Citations -  200

Saeed Ghasemi is an academic researcher from University of Gilan. The author has contributed to research in topics: Chemistry & Gallic acid. The author has an hindex of 6, co-authored 21 publications receiving 145 citations. Previous affiliations of Saeed Ghasemi include Tabriz University of Medical Sciences.

Papers
More filters
Journal ArticleDOI

Functional liposomes in the cancer-targeted drug delivery.

TL;DR: These novel systems were found very promising and encouraging dosage forms for the treatment of different types of cancer by increasing efficiency and reducing the systemic toxicity due to the specific drug delivery and targeting.

Novel Aldehyde-Terminated Dendrimers; Synthesis and Cytotoxicity Assay

TL;DR: The results showed that cytotoxicity of dendrimers with aldehyde-terminated groups is much lower than that of G1 and G2 PAMAM-NH2 dendri¬mers.
Journal ArticleDOI

Investigation of phenolic compounds and antioxidant activity of leaves extracts from seventeen cultivars of Iranian olive ( Olea europaea L.)

TL;DR: The identification analysis demonstrated the present of vanillin, rutin, luteolin 7-O-glucoside, oleuropein, and quercetin in cultivars Mishen, Beleidi, Kalamon, and Roghani while it was not detected in cultivar Conservolea, Amigdalolia, Leccino, and Fishomi.
Journal ArticleDOI

Pioglitazone prevents morphine antinociceptive tolerance via ameliorating neuroinflammation in rat cerebral cortex

TL;DR: It is concluded that oral administration of pioglitazone attenuates morphine-induced tolerance and neuroinflammation in the cerebral cortex of the rat and may be, at least in part, due to its anti-inflammatory property which suppressed the cortical pro-inflammatory cytokine and inhibited of nuclear factor-kappa B activity.
Journal ArticleDOI

Comparison of Cytotoxic Activity of L778123 as a Farnesyltranferase Inhibitor and Doxorubicin against A549 and HT-29 Cell Lines.

TL;DR: It can be concluded that L778, 123 can be a good agent for combination therapy if used alone and in combination with doxorubicin against A549 and HT29 cell lines by MTT assay.